摘要
对肿瘤患者来说表皮生长因子受体(EGFR)是一个很有吸引力的的治疗靶点,PET—CTEGFR显像可以反映EGFR的活性,可能成为检测EGFR更可靠的指标。近年来,用PET—CTEGFR显像筛选肿瘤靶向治疗药物已经成为PET—CT临床应用研究的热点和重点。
Epidermal growth factor receptor (EGFR) is a promising therapeutic target for cancer patients. Its activity can be reflected by PET-CT EGFR imaging which became a more reliable indicator to measure EGFR. In recent years, PET-CT EGFR imaging was adopted to screen targeted drugs, which became a hot topic in the clinical application of PET-CT.
出处
《国际放射医学核医学杂志》
2010年第5期266-268,共3页
International Journal of Radiation Medicine and Nuclear Medicine